Samuel Z. Goldhaber, MD, offers insight into how healthcare providers can protect medically ill patients from developing VTE and stroke.
From the 19th Annual Antithrombotic Therapy Symposium, Wayne State University
Related Articles
September 17, 2018
Clot Chronicles: Atrial Fibrillation Awareness Month
September is Atrial Fibrillation Awareness Month! In this episode of the Clot Chronicles, Dr. Sam Goldhaber discusses impact of atrial…
September 5, 2018
DOAC Reversal Deep Dive: A Look At Andexanet Alfa
By Katelyn Sylvester, PharmD, CACP, BCPS For the past several decades, warfarin has been the only FDA-approved oral anticoagulant for…
August 30, 2018
Clot Chronicles: Busting Out Pulmonary Embolism
Dr. Samuel Goldhaber discusses the latest developments in tPA. Hello, This is Dr. Sam Goldhaber. I am president of NATF,…